Drugs / FT061452
FT061452
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01251315 Comparator | Dec 2010 → Jun 2011 | — | Charles Drew University of Medicine and Science | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FT061452 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01251315 ↗ |
| Known as | Proimmune 200 | “Proimmune 200 (FT061452)” NCT01251315 ↗ |
| Known as | Proimmune-200 (FT061452) | “Proimmune-200 (FT061452)” NCT01251315 ↗ |
| Route | Oral | “administration of a novel oral glutathione precursor, FT061452” NCT01251315 ↗ |